These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 3834613

  • 1. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
    Kong DS, Yeo SH.
    Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
    [No Abstract] [Full Text] [Related]

  • 2. Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
    Coufal J, Novotný M.
    Act Nerv Super (Praha); 1981 Dec; 23(4):269-71. PubMed ID: 6121439
    [No Abstract] [Full Text] [Related]

  • 3. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS, Yeo SH.
    Pharmatherapeutica; 1989 Dec; 5(6):371-9. PubMed ID: 2687894
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Experience with depot neuroleptics].
    Arató M, Erdós A.
    Orv Hetil; 1979 Apr 29; 120(17):1015-21. PubMed ID: 372888
    [No Abstract] [Full Text] [Related]

  • 10. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
    Turbott J, Villiger J, Hunter L.
    Aust N Z J Psychiatry; 1987 Sep 29; 21(3):327-38. PubMed ID: 3435373
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A, Okasha MS, Salih MA, Hirsch SR.
    Br J Psychiatry; 1979 Dec 29; 135():515-23. PubMed ID: 394794
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
    Turbott J, Villiger J, Hunter L.
    Br J Psychiatry; 1985 Apr 29; 146():439-42. PubMed ID: 4016448
    [Abstract] [Full Text] [Related]

  • 17. Flupentixol and flupentixol decanoate, with special reference to their antipsychotic effect.
    Gottfries CG.
    Acta Psychiatr Belg; 1974 Sep 29; 74(5):507-16. PubMed ID: 4620362
    [No Abstract] [Full Text] [Related]

  • 18. Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison.
    Eberhard G, Hellbom E.
    Acta Psychiatr Scand; 1986 Sep 29; 74(3):255-62. PubMed ID: 3788652
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B.
    Acta Psychiatr Scand; 1981 Jul 29; 64(1):65-84. PubMed ID: 7032224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.